|
|
Clinical Data, Inc. - Sales Analysis Snapshot
Business Description This Report provides a comprehensive Sales & Margin summary analysis for Clinical Data, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
Clinical Data, Inc.. The Group's principal activity is to focus on the development and commercialization of targeted therapeutics and predictive tests, and to provide world-leading value-based genomic solutions to both the healthcare and life sciences industries. The Group operates business in two segments: PGxHealth and Cogenics. It operates in the United States, North America, Europe, Asia and Other foreign countries. The Group also acquired Epidauros Biotechnologie A.G. last August 23, 2007.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|